Lilly and the biopharmaceutical industry have made remarkable advances in the fight against disease. EU citizens can now expect to live 30 years longer than they did 100 years ago. Death rates from cancer have fallen by 20% over the last 20 years.
But more work remains to be done. Our industry has 7,000 new medicines in development as we try to unlock the next breakthrough. #WeWontRest is an industry-wide, European campaign that shines the spotlight on the people who work to discover and develop new medicines for patients. Read about the researchers and many others that Lilly feature in #WeWontRest.